J Allen, MM McCambridge, H Kincaid, JA Kalter - Cureus, 2021 - ncbi.nlm.nih.gov
Objective Coronavirus disease 2019 (COVID-19) is associated with diffuse lung injury that can progress to acute respiratory distress syndrome, multisystem-organ failure, and death …
KEN Clark, WD Nevin, T Mahungu… - Clinical Infectious …, 2021 - academic.oup.com
The clinical manifestation of moderate to severe coronavirus disease 2019 (COVID-19) has parallels to secondary hemophagocytic lymphohistiocytosis (HLH) both clinically and based …
Background COVID-19, a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly presents as fever, cough, dyspnea, and myalgia or …
A Prilutskiy, M Kritselis, A Shevtsov… - American journal of …, 2020 - academic.oup.com
Objectives A subset of coronavirus disease 2019 (COVID-19) patients exhibit clinical features of cytokine storm. However, clinicopathologic features diagnostic of …
P Kalita, D Laishram, B Dey, J Mishra, B Barman… - Cureus, 2021 - ncbi.nlm.nih.gov
Hemophagocytic lymphohistiocytosis (HLH) is a disease that can affect both children and adults. HLH can be categorized as primary or secondary. Secondary HLH (sHLH) may be …
Interventions: A treatment regimen of methylprednisolone, pentaglobin, and anakinra was developed and administered. Outcomes: One patient survived the ICU stay. Two other …
R Chu, C van Eeden, S Suresh, WI Sligl… - International journal of …, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality …
ABSTRACT A significant proportion of COVID-19 patients show evidence of hyperinflammation (HI), of which secondary haemophagocytic lymphohistiocytosis (sHLH) is …
G Molina, R Contreras, K Coombes, T Walgamage… - Cureus, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with multiple inflammatory …